Prot #CM4620-205: A Single-Blind Dose-Ranging Pharmacodynamic Study of Auxora for the Treatment of Patients with Critical COVID-19 Pneumonia

Project: Research project

Project Details

StatusActive
Effective start/end date1/28/21 → 1/28/24

Funding

  • Emas Pharma Limited (Prot #CM4620-205)
  • CalciMedica, Inc. (Prot #CM4620-205)